H.B. 230
2023/01/22 16:49, Lead Analyst: Russell T. Frandsen Attorney: CW1
Fiscal Note
H.B. 230
2023 General Session
Center for Medical Cannabis Research
by Dailey-Provost, J.
General, Income Tax, and Uniform School Funds JR4-4-101
Ongoing One-time Total
Net GF/ITF/USF (rev.-exp.) $(2,500,000) $(1,640,000) $(4,140,000)
State Government UCA 36-12-13(2)(c)
Revenues FY 2023 FY 2024 FY 2025
Qualified Production Enterprise
Fund
$0 $2,500 $2,500
Total Revenues $0 $2,500 $2,500
Enactment of this legislation may increase ongoing revenue to the Qualified Production Enterprise
Fund by $2,500 beginning in FY 2024.
Expenditures FY 2023 FY 2024 FY 2025
Income Tax Fund $0 $2,500,000 $2,500,000
Income Tax Fund, One-time $0 $1,640,000 $1,720,000
Qualified Patient Enterprise Fund $0 $(76,300) $(76,300)
Qualified Production Enterprise
Fund
$0 $2,500 $2,500
Total Expenditures $0 $4,066,200 $4,146,200
Enactment of this legislation may cost the University of Utah from the Income Tax Fund (1) $2,500,000
ongoing in FY 2024, (2) $1,640,000 one-time in FY 2024, (3) $1,720,000 one-time in FY 2025, and (4)
$1,720,000 one-time in FY 2026 to create the Center for the Medical Cannabis Research. This funding
includes paying the $2,500 annual cost beginning in FY 2024 for an academic research cannabis
license. Additionally, this legislation may cost the Department of Agriculture $2,500 ongoing from
the Qualified Production Enterprise Fund beginning in FY 2024 for staff time to issue an academic
research cannabis license. Finally, this legislation may reduce ongoing costs beginning in FY 2024
for the Department of Health and Human Services by ($76,300) from the Qualified Patient Enterprise
Fund for the end of the Cannabis Research Review Board.
FY 2023 FY 2024 FY 2025
Net All Funds $0 $(4,063,700) $(4,143,700)
Local Government UCA 36-12-13(2)(c)
Enactment of this legislation likely will not result in direct, measurable costs for local governments. H.B. 230
2023/01/22 16:49, Lead Analyst: Russell T. Frandsen Attorney: CW1
Individuals & Businesses UCA 36-12-13(2)(c)
Enactment of this legislation likely will not result in direct expenditures from tax or fee changes for Utah
residents and businesses.
Regulatory Impact UCA 36-12-13(2)(d)
Enactment of this legislation likely will not change the regulatory burden for Utah residents or
businesses.
Performance Evaluation JR1-4-601
This bill does not create a new program or significantly expand an existing program.
Notes on Notes
Fiscal notes estimate the direct costs or revenues of enacting a bill. The Legislature uses them to balance the budget. They do not measure a bill's
benefits or non-fiscal impacts like opportunity costs, wait times, or inconvenience. A fiscal note is not an appropriation. The Legislature decides
appropriations separately.